title: Role of dyslipidemia in patients with chronic kidney disease.
authors.affiliation: Division of Endocrinology and Molecular Medicine, University of Kentucky, Lexington, KY, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Marino
authors.forename: Lisa R
authors.initials: LR
authors.lastname: Tannock
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D050171:Dyslipidemias / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006951:Hyperlipoproteinemias / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D015228:Hypertriglyceridemia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D052456:Hypoalphalipoproteinemias / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents